Foy Matthew
Insider CIK 1842129 · DBTX Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,737,619 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 7,119,852 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 3,125,000 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | P Buy | 2021-02-17 | 2021-02-19 | 150,000 | $18.00 | $2.70M | 1,183,663 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 327,852 | — | $0 | 1,033,663 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 247,324 | — | $0 | 705,811 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 458,487 | — | $0 | 458,487 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | A Award deriv | 2021-02-11 | 2021-02-16 | 20,000 | — | $0 | 20,000 | SEC↗ |